A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
Clinical trial NCT06041269 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06041269
- Sponsor
- AnaptysBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2024-11-29
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.